A Phase IV Study in Subjects With Neurogenic Orthostatic Hypotension

PHASE4TerminatedINTERVENTIONAL

Enrollment

150

Participants

Timeline

Start Date

September 5, 2002

Primary Completion Date

August 6, 2003

Study Completion Date

August 6, 2003

Conditions

Hypotension, Orthostatic

Interventions

DRUG

midodrine hydrochloride (ProAmatine®)

Trial Locations (3)

Suncoast Neuroscience Associates, Inc., St. Petersburg

Neurological Associates of Delaware Valley, Upland

Diabetes & Glandular Disease Research Associates, PA,, San Antonio